Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
Rhea-AI Summary
Lantheus (NASDAQ: LNTH) will host a conference call and webcast at 8:00 a.m. ET on February 26, 2026 to discuss fourth quarter and full year 2025 financial and operating results. Participants should register online and are encouraged to register 15 minutes early to avoid delays.
A replay will be available approximately two hours after the webcast and archived on the events page for at least 30 days. Access registration at the company events calendar.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
LNTH’s slight move of 0.16% came as close peers showed mixed, low-single-digit changes (e.g., ALKS +0.06%, AMRX -0.94%, HCM +1.14%), suggesting a company-specific, routine catalyst rather than a coordinated sector move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 23 | Q3 2025 earnings call | Neutral | -1.1% | Scheduled Q3 2025 earnings call and webcast with replay details. |
| Jul 23 | Q2 2025 earnings call | Neutral | +1.3% | Announced Q2 2025 earnings call timing and registration information. |
| Apr 23 | Q1 2025 earnings call | Neutral | +1.6% | Set date and time for Q1 2025 earnings webcast and replay. |
| Feb 12 | FY 2024 earnings call | Neutral | +0.2% | Announced Q4 and full-year 2024 earnings call schedule and access. |
| Oct 23 | Q3 2024 earnings call | Neutral | -1.8% | Scheduled Q3 2024 earnings call and provided webcast logistics. |
Earnings call scheduling headlines have historically produced very small, mixed share-price moves, indicating these events are treated as routine.
Over the past five quarters, Lantheus has regularly announced earnings conference calls with a similar structure: early-morning 8:00 a.m. ET webcasts, advance registration via the investor site, and 30-day replays. Market reactions to these call-scheduling releases have been modest, with single-day moves ranging from about -1.8% to +1.6%. Today’s announcement for the Q4 and full-year 2025 call fits this established pattern of procedural communication rather than major new information.
Historical Comparison
Past earnings-call scheduling headlines for LNTH produced near-flat average moves of about 0.07%, suggesting markets typically treat these as routine notices.
The company has maintained a consistent cadence of quarterly earnings calls from 2024 through 2025, each pre-announced with similar timing, format, and replay provisions.
Market Pulse Summary
This announcement schedules Lantheus’ Q4 and full-year 2025 earnings call for February 26, 2026 at 8:00 a.m. ET, with registration via the investor website and a replay available for at least 30 days. Historically, similar call-scheduling releases have produced only very small share-price moves, indicating they are viewed as routine. Investors may focus instead on the forthcoming detailed results and guidance discussed during the call.
AI-generated analysis. Not financial advice.
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and operating results for the fourth quarter and full year of 2025.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland, and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com